Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,908,184
-
Share change
-
-332,735
-
Total reported value
-
$12,888,266
-
Put/Call ratio
-
117%
-
Price per share
-
$1.63
-
Number of holders
-
39
-
Value change
-
-$610,866
-
Number of buys
-
10
-
Number of sells
-
31
Institutional Holders of MILLENDO THERAPEUTICS INC - COM (MLND) as of Q3 2020
As of 30 Sep 2020,
MILLENDO THERAPEUTICS INC - COM (MLND) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,908,184 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, Ghost Tree Capital, LLC, CITADEL ADVISORS LLC, Bpifrance SA, RENAISSANCE TECHNOLOGIES LLC, Anson Funds Management LP, VANGUARD GROUP INC, AWM Investment Company, Inc., and WINTON GROUP Ltd.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.